Case series suggests biologics, JAK inhibitors safe during pandemicMay 1, 2020COVID-19 UpdatesRheumatologyDermatologyGastroenterology
Adalimumab serum levels and anti-drug antibodies fail to predict responses to other TNFiApril 28, 2020Rheumatology
Price increases for RA biologics keep out-of-pocket costs high for Medicare patientsApril 27, 2020Rheumatology
COVID-19: Frequently asked clinical questionsApril 24, 2020COVID-19 UpdatesBusiness of MedicineRheumatologyPulmonologyDermatologyPreventive Care
Latest data on COVID-19 patients with rheumatic diseases revealed in registryApril 23, 2020COVID-19 UpdatesRheumatology
Financial incentives affect the adoption of biosimilarsApril 16, 2020Business of MedicineRheumatologyGastroenterologyDermatology
Most e-consults not followed by specialist visitApril 15, 2020Business of MedicineDermatologyHematologyInfectious DiseasesRheumatologyMental Health
